Am J Transplant, Volume 21, Suppl 3 Archives - Page 70 of 139 - ATC Abstracts

2021 American Transplant Congress
Health-related Quality of Life (HRQoL) in Patients on Dialysis and Kidney Transplant Recipients – Experience with the PROMIS Global-10 Survey
G. Chawla, W. Hajjar, M. Dastgheib, N. Yanga, G. Ahmadzadeh, N. El-Dassouki, A. Shahreza, N. Al Kaabi, N. Edwards, I. Mucsi
University Health Network, Division of Nephrology and Multi-Organ Transplant Program, Toronto, ON, Canada
*Purpose: The PROMIS (Patient-Reported Outcomes Measurement Information System) Global-10 survey has been used to assess HRQoL in population surveys and studies including patients with chronic…
2021 American Transplant Congress
Information-Seeking Behavior During Covid-19: Opportunities for Communication and Care Transition Improvements
S. H. Advani¹, S. M. Advani², Y. A. Iraheta³, A. Murillo⁴, H. A. Gritsch³, A. D. Waterman³
¹Terasaki Institute, Bethesda, MD, ²National Human Genome Research Institute, Bethesda, MD, ³UCLA, Los Angeles, CA, ⁴Terasaki Institute, Los Angeles, CA
*Purpose: To learn more about how at-risk dialysis and transplant patients sought health information during COVID-19 and what was most helpful, we conducted a mixed-methods…
2021 American Transplant Congress
The Seattle Heart Failure Model is a Predictor of Mortality After Kidney Transplant in Patients with End Stage Renal Disease and Heart Impairment
A. Perez-Gutierrez¹, P. J. Bachul², D. N. Danz³, B. Juengel², M. Josephson², J. Fung², P. Witkowski², B. Chung⁴, Y. Becker²
¹Surgery, University of Chicago, Chicago, IL, IL, ²Surgery, University of Chicago, Chicago, IL, ³Economics, University of Pittsburgh, Pittsburgh, IL, ⁴Cardiology, University of Chicago, Chicago, IL
*Purpose: Cardiovascular disease is the main cause of mortality after kidney transplantation. Many patients with ESRD have heart failure that is attributed to fluid overload.…
2021 American Transplant Congress
Safety and Tolerability of Tacrolimus Extended-Release (astagraf Xl) in Hla Sensitized Kidney Transplant Recipients: A Single Center Experience
A. A. Vo, N. Ammerman, E. Huang, A. Peng, R. Najjar, S. Sethi, K. Lim, M. Gillespie, S. C. Jordan
Cedars Sinai Medical Ctr, Los Angeles, CA
*Purpose: Pill burden is a limitation in kidney transplant. Tacrolimus extended-release (Astagraf XL) is a once daily formulation approved for kidney transplantation. Increased compliance could…
2021 American Transplant Congress
Calcineurin Inhibitor Dose and Selection, Not Antiproliferatives or Steroids, Influence Development of DSA One Year Post-kidney Transplant
M. Henderson¹, G. Morris², L. Awdishu¹, K. Fabbri¹, M. Shah³, A. Khan³, J. Kerr¹
¹Pharmacy, University of California San Diego Health, San Diego, CA, ²Pathology, University of California San Diego Health, San Diego, CA, ³Nephrology, University of California San Diego Health, San Diego, CA
*Purpose: Allograft rejection is a serious complication in kidney transplantation (KT). Despite advances in immunosuppression, acute rejection remains a concern in the first year of…
2021 American Transplant Congress
Factors Affecting Sensitization Following Kidney Allograft Failure
N. Garg, L. Hidalgo, S. Parajuli, F. Aziz, M. Mohamed, A. Djamali, D. Mandelbrot
UW Madison, Madison, WI
*Purpose: Kidney transplant (KT) recipients with failed allografts constitute nearly 12% of the current waitlist in the US. Sensitization as a result of graft failure…
2021 American Transplant Congress
The Evaluation of Living-Related Kidney Transplantation Donors in Autosomal-Dominant Polycystic Kidney Disease
T. Kikuchi¹, K. Unagami², Y. Kobari³, T. Yagisawa³, T. Kanzawa³, K. Omoto³, A. Uemura¹, H. Ishida², K. Tanabe³
¹Urology, Kindai University Hospital, Osaka, Japan, ²Organ transplant medicine, Tokyo Women's Medical University Hospital, Tokyo, Japan, ³Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan
*Purpose: Autosomal-dominant polycystic kidney disease (ADPKD) is a progressive hereditary disease caused primarily by gene mutations, leading to multiple kidney cyst occurrence, kidney function deterioration,…
2021 American Transplant Congress
Urine Donor-derived Cell-free is Valuable for Predicting BK Polyomavirus-associated Nephropathy in Kidney Transplant Recipients
G. Huang¹, X. Chen¹, Y. Huang¹, J. Li¹, R. Deng¹, W. Chen², J. Qiu¹, S. Deng¹, G. Chen¹, Q. Fu¹, C. Wu¹, J. Fei¹, L. Liu¹, L. Chen¹, C. Wang¹
¹Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: Our previous study has proved that urine donor-derived cell-free DNA (dd-cfDNA) can assist in the diagnosis of BK polyomavirus-associated nephropathy (BKPyVAN), but its specificity…
2021 American Transplant Congress
Kidney Transplantation from Offspring to Mothers is Not Associated with Adverse Outcomes
S. Parajuli, N. Garg, A. Djamali, D. Mandelbrot
University of Wisconsin, Madison, WI
*Purpose: Due to concerns of donor-specific alloimmunization during pregnancy, some have suggested avoiding living donor kidney transplants (LDKT) from offspring to biological mothers. Published analyses…
2021 American Transplant Congress
Improving Allograft Survival by Informing Donor Selection in Kidney Transplant Recipients Under 5 Years Old
F. Manca Barayre, L. Greenbaum, R. Garro, P. Winterberg, R. Patzer, J. Hogan
Emory University, Atlanta, GA
*Purpose: The kidney allocation system aims at allocating high-quality kidneys in pediatric recipients but the KDPI score used to assess the quality of the donors…